• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Ljudböcker
  • Pocketböcker
  • Spel och pussel

Skapa nya rutiner – hälsoböcker upp till 50% →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Klinisk medicin och internmedicin
    3. Sjukdomar och rubbningar
    4. Onkologi

    50 Big Debates in Gynecologic Oncology

    AvDennis S. Chi,Nisha Lakhi

    Häftad, Engelska, 2023

    496 kr

    Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Highlighting over 50 hot topics where controversy exist in management of patients with gynecologic malignancy, this book presents expertly argued opinions for and against, incorporating current evidence and clinical trials outcomes. A diverse range of topics are included that pertain to several disciplines in gynecologic oncology, including surgical management of disease, medical oncology, immunotherapy, radiation therapy, as well as screening, preventive and palliative care. This book will be relevant to a diverse audience of practitioners and trainees including gynecologists, gynecological oncologists, surgeons, medical oncologists, radiation oncologists, and general medics. It will be a useful guide for practicing clinicians managing their patients, as well as a concise textbook for trainees and students preparing for examinations and board certifications in gynecologic oncology. Readers will gain an insight into topical controversies, critically evaluating the different sides to enhance their own clinical practice.

    Produktinformation

    • Utgivningsdatum:2023-08-03
    • Mått:155 x 235 x 19 mm
    • Vikt:536 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:224
    • Förlag:Cambridge University Press
    • ISBN:9781108940801

    Utforska kategorier

    • Onkologi inom Medicin
    • Onkologisk kirurgi inom Medicin
    • Gynekologi och obstetrik inom Medicin

    Mer om författaren

    Dennis S. Chi is the Ronald O. Perelman Chair in Gynecologic Surgery, Deputy Chief of the Gynecology Service, and Head of Ovarian Cancer Surgery at Memorial Sloan Kettering Cancer Center, New York, NY. Nisha Lakhi is the Senior Director of Clinical Oncology and Director of Research at Richmond University Medical Center, Staten Island, NY. She lead her institution's Cancer Program with special emphasis on gynecologic oncology and cancer survivorship and recently received the national “40 under 40 Cancer Award (2019)”. Nicoletta Colombo is Professor of Gynecological Oncology, University of Milan-Bicocca. She was President of ESGO from 2011-2013, chair of the ESMO-ESGO-ESP consensus Conference on endometrial Cancer in 2016 and Chair of ESMO-ESGO Ovarian Cancer Consensus Conference in 2019. She is chair elect of ENGOT (2022-2024).

    Innehållsförteckning

    • Section I: Perioperative Management; 1A. Should routine mechanical bowel preparation be performed before primary debulking surgery? Yes Lea A. Moukarzel and Oliver Zivanovic; 1B. Should routine mechanical bowel preparation be performed before primary debulking surgery? No Shannon Armbruster and Fidel A. Valea; 2A . Should preoperative carbohydrate loading be routine prior to debulking surgery? Yes Arwa Mohammad, Deepa Maheswari M. Narasimhulu and Sean C. Dowdy; 2B. Should preoperative carbohydrate loading be routine prior to debulking surgery? No Kathryn Miller, Dib Sassine and Yukio Sonoda; Section II: Screening, Prevention and Early Diagnosis; 3A. Should women with BRCA mutations be offered bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction? Yes Thomas Boerner and Kara Long Roche; 3B. Should women with BRCA mutations be offered bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction? No Steven A. Narod; 4A. Can high-risk HPV testing be used alone as the primary screening modality for cervical cancer? Yes Thomas C. Wright; 4B. Can high-risk HPV testing be used alone as the primary screening modality for cervical cancer? No Ibraheem O. Awowole and Olusegun O. Badejoko; Section III: Ovarian Cancer; 5A. Should CA-125 surveillance be performed after completion of primary treatment for ovarian cancer patients in remission? Yes Eseohi Ehimiaghe and Edward Tanner; 5B. Should CA-125 surveillance be performed after completion of primary treatment for ovarian cancer patients in remission? No Gordon J. S. Rustin; 6A. In patients with BRCA-negative and HRD-negative epithelial ovarian cancer, should molecular profiling be routinely done to guide adjuvant therapy? Yes Ilaria Betella and Matteo Repetto; 6B. In patients with BRCA-negative and HRD-negative epithelial ovarian cancer, should molecular profiling be routinely done to guide adjuvant therapy? No Raanan Alter and Ernst Lengyel; 7A. Is MEK Inhibitor Therapy the Best Treatment Recommendation for Low-Grade Serous Ovarian Cancer Patients at First Relapse? Yes Rachel N. Grisham; 7B. Is MEK Inhibitor Therapy the Best Treatment Recommendation for Low-Grade Serous Ovarian Cancer Patients at First Relapse? No David M. Gershenson; 8A. Should Stage IC mucinous ovarian carcinoma be managed by observation or adjuvant chemotherapy? Observation Jason D. Wright; 8B. Should Stage IC mucinous ovarian carcinoma be managed by observation or adjuvant chemotherapy? Adjuvant chemotherapy Jonathan Ledermann and Sophia Wong; 9A. How many cycles of adjuvant chemotherapy should be administered to patients with high-risk Stage I epithelial ovarian cancer? Three cycles Annalisa Garbi, Eleonora Zaccarelli and Federica Tomao; 9B. How many cycles of adjuvant chemotherapy should be administered to patients with high-risk Stage I epithelial ovarian cancer? Six cycles John K. Chan and Daniel S. Kapp; 10A. Patients with advanced ovarian cancer who are 75 years old and older should routinely be treated withneoadjuvant chemotherapy: Yes Michelle Davis and Ursula Matulonis; 10B. Patients with advanced ovarian cancer who are 75 years old and older should routinely be treated with neoadjuvant chemotherapy: No Olga T. Filippova and William P. Tew; 11A. Should an attempt at aggressive cytoreduction be made for all surgical candidates with advanced ovarian cancer prior to treatment with adjuvant chemotherapy? Yes Sven Mahner, Anca Chelariu-Raicu and Fabian Trillsch; 11B. Should an attempt at aggressive cytoreduction be made for all surgical candidates with advanced ovarian cancer prior to treatment with adjuvant chemotherapy? No Sean Kehoe and Jason Yap; 12A. Should minimally invasive modalities be routinely/uniformly utilized for assessment of resectability prior to attempted primary debulking in patients with advanced ovarian cancer? Yes Juliet E. Wolford
    Hoppa över listan

    Du kanske också är intresserad av

    Nicoletta Colombo, Nisha Lakhi, Dennis S. Chi - 50 Big Debates in Gynecologic Oncology, E-bok

    50 Big Debates in Gynecologic Oncology

    Nicoletta Colombo, Nisha Lakhi, Dennis S. Chi

    E-bok
    2023

    602 kr

    Nicoletta Colombo, Nisha Lakhi, Dennis S. Chi - 50 Big Debates in Gynecologic Oncology, E-bok

    50 Big Debates in Gynecologic Oncology

    Nicoletta Colombo, Nisha Lakhi, Dennis S. Chi

    E-bok
    2023

    602 kr

    Azadeh Nezhat, Nisha Lakhi, Ceana Nezhat, Farr R. Nezhat, Camran R. Nezhat - Nezhat's Textbook of Minimally Invasive Surgery, E-bok

    Nezhat's Textbook of Minimally Invasive Surgery

    Azadeh Nezhat, Nisha Lakhi, Ceana Nezhat, Farr R. Nezhat, Camran R. Nezhat

    E-bok
    2025

    3 259 kr

    Azadeh Nezhat, Nisha Lakhi, Ceana Nezhat, Farr R. Nezhat, Camran R. Nezhat - Nezhat's Textbook of Minimally Invasive Surgery, E-bok

    Nezhat's Textbook of Minimally Invasive Surgery

    Azadeh Nezhat, Nisha Lakhi, Ceana Nezhat, Farr R. Nezhat, Camran R. Nezhat

    E-bok
    2025

    3 250 kr

    Nisha Lakhi - Alpha-Fetoprotein: Functions and Clinical Applications, E-bok

    Alpha-Fetoprotein: Functions and Clinical Applications

    Nisha Lakhi

    E-bok
    2019

    4 339 kr

    Camran R. Nezhat, Farr R. Nezhat, Ceana Nezhat, Nisha Lakhi, Azadeh Nezhat - Nezhat's Textbook of Minimally Invasive Surgery, Inbunden

    Nezhat's Textbook of Minimally Invasive Surgery

    Camran R. Nezhat, Farr R. Nezhat, Ceana Nezhat, Nisha Lakhi, Azadeh Nezhat

    Inbunden, 2025

    2 648 kr

    Klara Ingemyr - SIGNERAD - Klaras husman, Kartonnage
    • Signerad!

    SIGNERAD - Klaras husman

    Klara Ingemyr

    Kartonnage, 2026

    269 kr

    Carola Häggkvist - SIGNERAD - Jag är Carola, Inbunden
    • Signerad!

    SIGNERAD - Jag är Carola

    Carola Häggkvist

    Inbunden, 2026

    269 kr

    Marcus Frank - SIGNERAD - Mackans kost : Middagar och matlådor, Inbunden
    • Signerad!

    SIGNERAD - Mackans kost : Middagar och matlådor

    Marcus Frank

    Inbunden, 2026

    269 kr

    Frida Gråsjö - Vatten över huvudet, Pocket
    • -45%
    Del 1

    Vatten över huvudet

    Frida Gråsjö

    Pocket, 2024

    3,4 utav 5 stjärnor. Totalt antal röster:(26)

    49 kr89 kr